Business · 05/10/1998Updated: 10/17/2026 · 1 min read
FDA Withdraws Approval of Terfenadine Drug Applications
Summary
The FDA is withdrawing approval of two new drug applications and one abbreviated new drug application for terfenadine, a medication used to treat seasonal allergic rhinitis, due to safety concerns.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →